Cited by 146Antifungal resistance and susceptibilityYeasts and Rust Fungi StudiesFungal Infections and Studies

Candida auris : An emerging multidrug-resistant pathogen

Open access
Sears, David, Schwartz, Brian S.·2017·International Journal of Infectious Diseases

Abstract

Candida aurisis an emerging multidrug-resistant pathogen that can be difficult to identify using traditional biochemical methods. C. auris is capable of causing invasive fungal infections, particularly among hospitalized patients with significant medical comorbidities. Echinocandins are the empiric drugs of choice for C. auris, although not all isolates are susceptible and resistance may develop on therapy. Nosocomial C. auris outbreaks have been reported in a number of countries and aggressive infection control measures are paramount to stopping transmission.

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2017.08.017

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 36 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Sears, D., & Schwartz, B. S.
Affiliations
University of California, San Francisco (US)
Corresponding author
Sears, David
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2017-10
Volume
63
Pages
95-98
ISSN
1201-9712 (ISSN-L)
OpenAlex
W2752772336
Cited by
146
References
36
Citations by year
2026: 8 · 2025: 8 · 2024: 10 · 2023: 7 · 2022: 18 · 2021: 16 · 2020: 26 · 2019: 30 · 2018: 22 · 2017: 1
FWCI
3.31
Type
journal article
Language
en
Open access
Locations
  • International Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
Candida auris, multidrug resistance, invasive fungal infections, echinocandins, antifungal susceptibility, hospital outbreak, infection control, nosocomial infections, emerging fungal pathogens
MeSH terms
Antifungal Agents, Candida, Candidiasis, Cross Infection, Dose-Response Relationship, Drug, Humans, Microbial Sensitivity Tests, Infection Control, Communicable Diseases, Emerging, Drug Resistance, Multiple, Fungal, Echinocandins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review